Accelerator · 2 deals
Accelerates commercialisation of evidence-based digital and connected health technologies in Australia.
Every published round ANDHealth took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted, and a place in one of its own programs is under Cohorts.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Neurotologix | Grant | 12 Aug 2026 | $2m | Participant | Dealroom (21 Aug 2026), Dealroom (13 Aug 2026) | |
| Aleris Therapeutics | Grant | 12 Aug 2026 | $2.5m | Participant | Dealroom (21 Aug 2026), Dealroom (13 Aug 2026) |
Everyone ANDHealth has named to a program in published coverage. A place in a program is not a raise: the cheque is the figure recorded with the place, which is the program's standard terms where we hold them, and a blank is one we don't.
| Member | Program | Announced | Cheque | Sources |
|---|---|---|---|---|
| Baymatob | ANDHealth+ | undated | - | SmartCompany (8 Feb 2024), SmartCompany (5 Feb 2024), Alberts Impact Ventures portfolio |
| Macuject | ANDHealth+ | undated | - | SmartCompany (8 Feb 2024), SmartCompany (5 Feb 2024) |
| Neurotologix | ANDHealth+ | undated | - | SmartCompany (8 Feb 2024), SmartCompany (5 Feb 2024) |
| WeGuide | ANDHealth+ | undated | - | SmartCompany (8 Feb 2024), SmartCompany (5 Feb 2024) |
Companies ANDHealth has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Aleris Therapeutics | 12 Aug 2026, Grant | 1 | 0 | |
| Baymatob | Developing an AI-powered maternal and foetal health platform ('Oli') that provides early … | Accelerator | 1 | 1 |
| Macuject | Accelerator | 1 | 1 | |
| Neurotologix | 12 Aug 2026, Grant | 1 | 0 |
Fund closes reported for ANDHealth, as distinct from the investments it has made.
Companies ANDHealth has backed that another company then bought. An exit for the holding, not a deal ANDHealth did.
| Name | Role | Sources |
|---|---|---|
| Aenor Sawyer | Committee Member | Startup Daily |
| Anand Iyer | Committee Member | Startup Daily |
| Andrew Murphy | Committee Member | Startup Daily |
| Bill Lucia | Committee Member | Startup Daily |
| Bronwyn Le Grice | Chief Executive | SmartCompany, Women's Agenda, Startup Daily (20 Dec 2021), Startup Daily (23 Nov 2021) |
| Dr Kate Merton | Committee Member | Startup Daily |
| Drew Schiller | Committee Member | Startup Daily |
| Ken Cahill | Committee Member | Startup Daily |
| Lisa Suennen | Chair | Startup Daily |
Stories naming ANDHealth. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne dementia drug developer Kinoxis secured $6.75 million equity led by Main Sequence plus a $2.5 million Medical Research Future Fund grant via CUREator+, funding trials of its agitation and pain drug candidates.
Australian medtech Ceretas hit a milestone in its CUREator+ program, unlocking the final instalment of a government-funded grant; the piece also recaps its A$8 million IPO and ASX listing earlier in 2026.
ANDHealth interviews John Shanks of Kraken Coding, whose Clinical Branches platform guides clinicians through guidelines in 72 hospitals, about joining its ANDHealth+ commercialisation program.
Six Australian health tech startups received non-dilutive grants totaling $13.5 million from the government-backed CUREator+ program to accelerate commercialisation of medical innovations.
Six Australian biomedical and health ventures receive a combined $13.5 million in non-dilutive grants through round two of the CUREator+ commercialisation program operated by Brandon BioCatalyst and backed by the Medical Research Future Fund.
Also Dealroom
Six Australian health tech startups received a combined $13.5 million in non-dilutive funding from the CUREator+ program, supported by the Australian Government.
CUREator+ granted thirteen point five million dollars in non-dilutive funding to six Australian health tech startups to support commercialisation of medical innovations.
ANDHealth's blog interviews Earflo co-founder Dr Intan Oldakowska about its FDA-cleared device for childhood ear infections, her entrepreneurial path, and the company's aims in the ANDHealth+ medtech program.
Interview with the chief executive of Adelaide heart-analytics startup Corcillum on its angiogram software, funding hurdles, and its place in the ANDHealth+ accelerator program.
ANDHealth's blog interviews Australis Scientific's founder about its wearable therapy for bladder conditions, its years in ANDHealth programs, and plans to scale the device at home and abroad.
ANDHealth+ selected five Australian digital and connected health companies to receive tranched, milestone-based non-dilutive funding across two stages totalling up to $9 million.
ANDHealth selected 15 Victorian digital health startups for its ACTIVATE 2026 scale-up program, backed by LaunchVic and the Victorian Government, spanning aged care to cancer support.
AndHealth has appointed Seer Medical's co-founder and former COO George Kenley as its 2026 ACTIVATE Executive in Residence; she will mentor Victorian digital health startups, with applications due 22 March.
ANDHealth appoints Anne O'Neill and George Kenley to senior leadership roles while outgoing COO Grace Lethlean departs after nine years.
ANDHealth launches applications for its 2026 ACTIVATE accelerator, citing record participant satisfaction and strong cumulative results across prior Victorian digital health cohorts.
Health technology governance veteran Sergio Duchini joins ANDHealth's board, adding capital markets and R&D commercialisation expertise to the digital health accelerator.
ANDHealth reported portfolio metrics including patient impact and job creation, while securing additional MRFF funding to expand its digital health commercialisation program.
Government-backed CUREator+ program awards non-dilutive funding to seven Australian companies developing dementia and cognitive decline therapeutics, devices and digital health tools.
ANDHealth secured a thirty-three million dollar government grant to expand its non-dilutive accelerator program for digital health startups, aiming to support fifteen companies over two years.
CUREator+, backed by Brandon BioCatalyst, ANDHealth and Dementia Australia, launches second round offering non-dilutive funding to startups targeting dementia and cognitive decline.
ANDHealth and LaunchVic named 15 Victorian digital health startups for the 2025 ACTIVATE accelerator cohort, with over half building AI-driven solutions.
Federal government funds Care Economy Cooperative Research Centre; ANDHealth appointed commercialisation partner to help translate care research into market-ready products.
Breakthrough Victoria highlights recent achievements of portfolio companies including funding, awards, and expansions for firms like Liquid Instruments, Quantum Brilliance, and Samsara Eco.
Eight Australian health startups received equity-free grants totaling 18.5 million dollars from the CUREator+ program, supported by government funding and delivered with partners Brandon BioCatalyst and ANDHealth.
Case study of Flintworks, a VR mental health startup co-founded by Tia Cummins and Pete Martin, covering its angel and pre-seed raises and its membership of ANDHealth's 2024 ACTIVATE accelerator cohort.
Five Australian digital health startups received a combined $3.25 million in stage-two grant funding from the Medical Research Future Fund, facilitated by ANDHealth.
ANDHealth announced its fourth accelerator cohort, granting non-dilutive MRFF funding to six digital health startups including Cape Bionics and Healthily to support commercialisation.
The CUREator+ incubator, backed by government funds and industry partners, launches its initial grant round offering non-dilutive capital to startups developing dementia and cognitive decline solutions.
ANDHealth and LaunchVic announced the 2024 ACTIVATE accelerator cohort, selecting fifteen Victorian digital health startups for a six-month program focused on commercialisation and investment readiness.
ANDHealth supports the Australian government's new national health research strategy and funding commitments, highlighting the role of its accelerator in driving digital health innovation.
Roundup of seven Australian startups landing fresh capital and grants: Gaia EnviroTech's $4.3 million deal with RFM, four medtechs sharing $3.25 million via ANDHealth+, Q-CTRL's UK quantum prize, and CarbonHQ's $600,000 pre-seed.
Four Australian medtech companies have received a share of $3.25 million through the ANDHealth+ program, with the money aimed at clinical milestones and global expansion.
Also SmartCompany
Techboard's May 2023 roundup of Australian startup funding: 42 private raises topped by Fleet Space's $50m round, two $40m acquisitions, multiple grants, accelerator intakes, and fund news including GiantLeap's $50m fund raise.
Biotech incubator CUREator's second round distributes $12 million among 19 health-focused startups, supported by government funding, while a new MedTech program backed by $50 million arrives later in the year.
CUREator, the national biotech incubator operated by Brandon BioCatalyst, selects 19 projects for its second funding round worth $12 million, and a $50 million MRFF award will add a MedTech stream.
Techboard's monthly roundup tallies October 2022 startup funding at $661m across 99 deals, listing megadeals such as Airwallex, acquisitions, Square Peg's $861m fund close and government grants to program operators.
Also @AuManufacturing
Podcast episode and feature profiling female founders tackling women's health, covering Ovira's funding journey, ANDHealth's female-founder numbers, the FemTech collective and Women's Health Road's new care model.
ANDHealth named five digital health startups, including child-focused Gheorg and Sound Scouts, for its inaugural ANDHealth+ cohort, sharing $3.75 million through its accelerator fund backed by government MRFF money.
ANDHealth has appointed US healthtech investor Lisa Suennen to lead a new international expert committee advising its government-funded digital health accelerator fund and ANDHealth+ program.
Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com